A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
300
Participants
Timeline
Start Date
April 30, 2006
Study Completion Date
August 31, 2007
Conditions
Affective Psychosis, BipolarBipolar DisorderMania
Interventions
DRUG
Paliperidone ER
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00309686 - A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder | Biotech Hunter | Biotech Hunter